The Insight Partners Latest Research for Report ” Diabetic Foot Ulcer Market Forecast to 2028” Includes COVID-19 Impact and Global Analysis By Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-Ischemic Ulcers), and End User (Hospitals, Ambulatory Surgery Centers and Home Care)
Research study on “Diabetic Foot Ulcer Market Forecast to 2028”- COVID-19 Impact and Global Analysis – by Type, Ulcer Type, and End-User,” the market is expected to reach US$ 7,793.83 million by 2028 from US$ 4,279.65 million in 2020; it is estimated to grow at a CAGR of 7.9% from 2021 to 2028.
Download PDF Sample Copy at:
The report highlights trends prevailing in the market and factors driving its growth. The growth of the diabetic foot ulcer market is mainly attributed to the factors such as the increasing prevalence of diabetes and related chronic wounds and rising geriatric population. However, the high cost of advanced wound care treatments hinders the market growth.
Segments – By Type:
Based on type, the diabetic foot ulcer market is segmented into advanced wound care dressings, biologics, and therapy device. The advanced wound care dressings segment held the largest market share in 2020, and it is expected to retain its dominance during the forecast period. The advanced wound care dressings offer more benefits than the traditional methods, such as gauze and tape. The advantages of advanced wound care dressings comprise faster healing time, less issues regarding drainage, and in certain instances, less risk of infection.
Based on end user, the diabetic foot ulcer treatment market is segmented into ambulatory surgical centers, hospitals, and home care. In 2020, the hospitals segment held the largest share of the market. Also, the market for the same segment is expected to grow at the fastest rate in the coming years owing to the availability of diabetologist, plastic surgeon, and other respective professionals in hospitals who take care of diabetic foot patients.
Leading Performers are:
- ConvaTec Group Plc
- Coloplast Group
- Smith & Nephew
- Braun Melsungen AG
- Medline Industries, Inc.
- Cardinal Health Inc
- Organogenesis Inc.
- Mölnlycke Health Care AB.
Have a Call with Analyst:
Overall company/segment revenue for the year 2019, 2018, and 2017 is provided in the sub title “Financial Performance” (public listed companies) along with the analysis and explanation of the increase or decrease in the same due to factors such as mergers & acquisition, profit or loss in any strategic business unit (SBUs) and others.
Product benchmarking comprises the comprehensive list of products pertaining to the respective market along with the application and key features.
Insights pertaining to the new product launch, strategic collaboration, mergers and acquisition, regulatory approval, and other developments by the company in market are covered under strategic initiatives section.
Buy Report at:
About The Insight Partners:
The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Manufacturing and Construction, Technology, Chemicals and Materials.
We offer our clients multiple ways to customize research as per their specific needs and budget.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi